Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Invasive Genetic Testing Procedures in Fetuses With Isolated Intrauterine Growth Restriction (IUGR) Diagnosed After 28 Weeks of Gestation at Strasbourg University Hospitals Between 2016 and 2023

NCT07864272 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT07864272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07864272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Invasive Genetic Testing Procedures in Fetuses With Isolated Intrauterine Growth Restriction (IUGR) Diagnosed After 28 Weeks of Gestation at Strasbourg University Hospitals Between 2016 and 2023
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Recruiting
Start date
January 12, 2026
Completion date
January 12, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

isolated intrauterine growth restriction (iugr)